Antonio Giordano, Clinical Director of Early Drug Development, Senior Physician of Breast Oncology Center at Dana-Farber Cancer Institute, shared a post on X:
“19 antibody drug conjugates approved globally, 15 are in the USA, over 400 ADCs in development, a new generation of ADCs under investigation. Dr. Daruka Mahadevan on pre-clinical consideration in ADC Development.”
More posts featuring ADCs on OncoDaily.